BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23391424)

  • 1. Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats.
    Kong LT; Wang Q; Xiao BX; Liao YH; He XX; Ye LH; Liu XM; Chang Q
    Fitoterapia; 2013 Apr; 86():48-53. PubMed ID: 23391424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
    Jeon JH; Lee J; Choi MK; Song IS
    Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal sensitivity to and enzymatic deglycosylation of ginsenosides.
    Zhao X; Gao J; Song C; Fang Q; Wang N; Zhao T; Liu D; Zhou Y
    Phytochemistry; 2012 Jun; 78():65-71. PubMed ID: 22449289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protopanaxatriol-type ginsenosides from the root of Panax ginseng.
    Zhu GY; Li YW; Hau DK; Jiang ZH; Yu ZL; Fong WF
    J Agric Food Chem; 2011 Jan; 59(1):200-5. PubMed ID: 21141994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-microemulsifying Drug Delivery System Improved Oral Bioavailability of 20(S)-Protopanaxadiol: From Preparation to Evaluation.
    Wang B; Pu Y; Xu B; Tao J; Wang Y; Zhang T; Wu P
    Chem Pharm Bull (Tokyo); 2015; 63(9):688-93. PubMed ID: 26084568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.
    Ren HC; Sun JG; Wang GJ; A JY; Xie HT; Zha WB; Yan B; Sun FZ; Hao HP; Gu SH; Sheng LS; Shao F; Shi J; Zhou F
    J Pharm Biomed Anal; 2008 Dec; 48(5):1476-80. PubMed ID: 19022601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fatigue Effects of 20(S)-Protopanaxadiol and 20(S)-Protopanaxatriol in Mice.
    Oh HA; Kim DE; Choi HJ; Kim NJ; Kim DH
    Biol Pharm Bull; 2015; 38(9):1415-9. PubMed ID: 26328499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-stress effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in immobilized mice.
    Oh HA; Kim DE; Choi HJ; Kim NJ; Kim DH
    Biol Pharm Bull; 2015; 38(2):331-5. PubMed ID: 25747994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption.
    Jin X; Zhang ZH; Li SL; Sun E; Tan XB; Song J; Jia XB
    Fitoterapia; 2013 Jan; 84():64-71. PubMed ID: 23006538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro.
    Lai L; Hao H; Liu Y; Zheng C; Wang Q; Wang G; Chen X
    Planta Med; 2009 Jun; 75(8):797-802. PubMed ID: 19266426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 20(S)-protopanaxatriol metabolites in rats by ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance spectroscopy.
    He C; Zhou D; Li J; Han H; Ji G; Yang L; Wang Z
    J Pharm Biomed Anal; 2014 Jan; 88():497-508. PubMed ID: 24184656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential accumulation of protopanaxadiol-type ginsenosides in six-months toxicokinetic study of SHENMAI injection in dogs.
    Yu J; Gu LQ; Xin YF; Bai YS; Zhang S; Gao HY; Xu PS; Ma ZF; You ZQ; Wang Z; Xuan YX
    Regul Toxicol Pharmacol; 2017 Feb; 83():5-12. PubMed ID: 27840091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of ginsenosides from white and red ginsengs in the simulated digestion model.
    Kim EO; Cha KH; Lee EH; Kim SM; Choi SW; Pan CH; Um BH
    J Agric Food Chem; 2014 Oct; 62(41):10055-63. PubMed ID: 25175701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Panax ginseng UDP-Glycosyltransferases Catalyzing Protopanaxatriol and Biosyntheses of Bioactive Ginsenosides F1 and Rh1 in Metabolically Engineered Yeasts.
    Wei W; Wang P; Wei Y; Liu Q; Yang C; Zhao G; Yue J; Yan X; Zhou Z
    Mol Plant; 2015 Sep; 8(9):1412-24. PubMed ID: 26032089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products from ginseng inhibit [3H]batrachotoxinin A 20-alpha-benzoate binding to Na+ channels in mammalian brain.
    Duan Y; Zheng J; Law V; Nicholson R
    Eur J Pharmacol; 2006 Jan; 530(1-2):9-14. PubMed ID: 16359658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylated protopanaxadiol-type ginsenosides from the root of Panax ginseng.
    Zhu GY; Li YW; Hau DK; Jiang ZH; Yu ZL; Fong WF
    Chem Biodivers; 2011 Oct; 8(10):1853-63. PubMed ID: 22006713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
    Popovich DG; Kitts DD
    J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of aglycone protopanaxatriol from ginseng root extract using Dictyoglomus turgidum β-glycosidase that specifically hydrolyzes the xylose at the C-6 position and the glucose in protopanaxatriol-type ginsenosides.
    Lee HJ; Shin KC; Lee GW; Oh DK
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3659-67. PubMed ID: 24136471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective pharmacokinetics of 25-methoxyl-dammarane-3β,12β,20-triol and its active demethyl-metabolite epimers in rats after oral and intravenous administration.
    Shao N; Jiang H; Wang X; Yuan B; Jin Y; Song M; Zhao Y; Xu H
    Fitoterapia; 2017 Jan; 116():139-145. PubMed ID: 27940119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of ginsenosides Rg1 and its metabolites in rats].
    Feng L; Hu CJ; Yu LY
    Yao Xue Xue Bao; 2010 May; 45(5):636-40. PubMed ID: 20931768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.